Stocks and Investing
Stocks and Investing
Fri, August 16, 2024
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
[ Fri, Aug 16th 2024
] - WOPRAI
Conor McNamara Reiterated (BIO) at Buy and Held Target at $401 on, Aug 16th, 2024
Conor McNamara of RBC Capital, Reiterated "Bio-Rad Laboratories, Inc." (BIO) at Buy and Held Target at $401 on, Aug 16th, 2024.
Conor has made no other calls on BIO in the last 4 months.
There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 1 agrees with Conor's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Patrick Donnelly of "Citigroup" Maintained at Hold with Increased Target to $350 on, Friday, August 2nd, 2024
This is the rating of the analyst that currently disagrees with Conor
- Dan Leonard of "UBS" Maintained at Strong Buy with Decreased Target to $385 on, Wednesday, May 8th, 2024
Contributing Sources